Bird Flu Outbreak in Cattle May Have Begun Months Earlier Than Thought
A single spillover, from a bird to a cow, led to the infections, a review of genetic data has found. (Source: NYT Health)
Source: NYT Health - April 24, 2024 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Avian Influenza Disease Rates Cattle Agriculture and Farming Dairy Products Viruses Milk Livestock Diseases Agriculture Department Food and Drug Administration Texas North Carolina Kansas Source Type: news

What to Do About Your Bunions
April Leonard likes to blame her bunions on her husband. In 2017, she accompanied him to a podiatrist appointment for calluses—and went home scheduled for surgery to correct her misaligned toe bone. In retrospect, it was a good thing. “He said, ‘I’d really like you to have this done now, because it won’t get better,’” recalls Leonard, 56, of that unexpected first conversation with the doctor. She had painful bunions on both feet and had started to have trouble handling daily chores on her farm in Missouri. Plus, she didn’t like how they looked. “When I went to the po...
Source: TIME: Health - April 24, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized Evergreen healthscienceclimate Source Type: news

Pasteurized milk includes remnants of H5N1 bird flu, U.S. officials say
The U.S. Food and Drug Administration says that it has found bird flu virus particles in some samples of pasteurized milk. (Source: CBC | Health)
Source: CBC | Health - April 24, 2024 Category: Consumer Health News Tags: News/Health Source Type: news

New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
WEDNESDAY, April 24, 2024 -- A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.That ’s because the U.S. Food and Drug Administration has approved the use of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 24, 2024 Category: General Medicine Source Type: news

Traces of bird flu found in pasteurized milk, FDA says, with virus traveling from birds, to cattle, to humans, and chickens
The U.S. Food and Drug Administration said Tuesday that samples of pasteurized milk had tested positive for remnants of the bird flu virus that has infected dairy cows. The agency stressed that the material is inactivated and that the findings “do not represent actual virus that may be a risk to…#fda #avian #leeannjaykus (Source: Reuters: Health)
Source: Reuters: Health - April 24, 2024 Category: Consumer Health News Source Type: news

US FDA Says Commercial Milk Safe Despite Bird Flu Virus Presence US FDA Says Commercial Milk Safe Despite Bird Flu Virus Presence
The U.S. Food and Drug Administration said on Tuesday that it had found bird flu virus particles in some samples of pasteurized milk, but said commercial milk supply remains...Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 23, 2024 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

FDA Urges Public to Use Heimlich Not'Anti-Choking' Devices to Save Lives
TUESDAY, April 23, 2024 -- The U.S. Food and Drug Administration is advising people to use the Heimlich maneuver to aid a choking victim and not rely on over-the-counter anti-choking devices. " The safety and effectiveness of over-the-counter... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2024 Category: Pharmaceuticals Source Type: news

FDA Roundup: April 23, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 23, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA grants accelerated approval to tovorafenib for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma
On April 23, 2024, the Food and Drug Administration granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement, or BRAF V600 mutati (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 23, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Column: FDA shoots itself in the foot by settling a groundless lawsuit over its ivermectin warnings
“You are not a horse”: The FDA’s 2021 consumer warning about not treating COVID with ivermectin, best known as a horse dewormer, was the most successful social media post in its history. “You are not a horse,” read a tweet posted by the Food and Drug Administration on Aug. 21, 2021. A fairly…#fda #linkedin #5thcircuits #donaldtrump #georgewbush #doritrubinsteinreiss #uccollegeoflaw #supremecourt #aduhelm #biogen (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2024 Category: Consumer Health News Source Type: news

FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS
On April 23, 2024, the Food and Drug Administration approved lutetium Lu 177 dotatate (Lutathera, Advanced Accelerator Applications USA, Inc., a Novartis company) for pediatric patients 12 years and older with somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NE (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 23, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Exo launches cardiac, lung AI apps for Exo Iris
Exo’s cardiac and lung AI applications are now available on Exo Iris, its handheld ultrasound device. The company released Exo Iris last year. The point-of-care-ultrasound (POCUS) device now features pulsed-wave Doppler capabilities to offer physicians more opportunities to assess blood velocity and thus support diagnosis and deeper findings in cardiac, abdominal, and vascular applications, according to the firm. Exo has U.S. Food and Drug Administration (FDA) 510k clearances for cardiac, lung, bladder, hip, and thyroid applications, and plans to double the number of clearances by 2025, it said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 23, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Stick to Heimlich Maneuver Not'Anti-Choking' Devices, FDA Says
TUESDAY, April 23, 2024 -- People should rely on the well-established Heimlich maneuver to save a choking victim, rather than newfangled “anti-choking” devices, the U.S. Food and Drug Administration says.“The safety and effectiveness of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 23, 2024 Category: General Medicine Source Type: news

FDA: Agency Information Collection Activities; Proposed Collection; Comment Request; Data To Support Social and Behavioral Research as Used by the Food and Drug Administration
Notice from the Food and Drug Administration (FDA) seeking comments on a proposed generic information collection to support social and behavioral research used by FDA about drug products. Comments are due by June 24, 2024. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - April 23, 2024 Category: Rural Health Source Type: news

FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 23, 2024 Category: Science Authors: Times staff Source Type: news